Literature DB >> 2627198

Biochemical and genetic studies on GP43, a 43-kD glycoprotein detected immunologically in human urine and serum.

K Mizuta1, T Yasuda, K Kishi.   

Abstract

A new and previously undescribed glycoprotein with a molecular weight of 43,000 has been isolated from human urine. This protein, designated GP43; copurified with ribonuclease, which has the same molecular weight, but ribonuclease activity was removed by passage through an affinity column of agarose-5'-(4-aminophenyl phosphoryl) uridine 2'(3') phosphate. GP43 contains about 5.9% neutral sugar, 2.3% hexosamine, and 1.6% sialic acid. A rabbit antibody to the purified GP43 reacted with human urine and serum as well as with the purified GP43. The genetic polymorphism of GP43 was then studied in desialylated human serum samples by urea-polyacrylamide gel isoelectric focusing, followed by immunoblotting with the specific antibody for GP43. Three common phenotypes, designated GP43 1, 1-2, and 2, were easily recognized using this technique and represented homozygosity or heterozygosity for two autosomal codominant alleles, GP43*1 and GP43/2. The frequencies of the GP43*1 and GP43*2 alleles in a Japanese population were 0.7683 and 0.2317, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2627198     DOI: 10.1007/bf02396064

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  2 in total

1.  Human serum deoxyribonuclease I (DNase I) polymorphism: pattern similarities among isozymes from serum, urine, kidney, liver, and pancreas.

Authors:  K Kishi; T Yasuda; Y Ikehara; K Sawazaki; W Sato; R Iida
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

2.  Discovery of a genetic polymorphism of human plasma protein C inhibitor (PCI): genetic survey utilizing isoelectric focusing followed by immunoblotting, immunological and biochemical characterization.

Authors:  T Yasuda; D Nadano; R Iida; Y Tanaka; M Nakanaga; K Kishi
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.